4:32 PM
 | 
Mar 01, 2018
 |  BC Week In Review  |  Clinical News  |  Regulatory

Daiichi submits Japanese application for esaxerenone

Exelixis Inc. (NASDAQ:EXEL) said Daiichi Sankyo Co. Ltd. (Tokyo:4568) submitted a regulatory application in Japan for esaxerenone (CS-3150) to treat hypertension,...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >